Home Infusion Therapy Global Market Opportunities And Strategies To 2035

Home Infusion Therapy Market Definition

Home infusion therapy is a healthcare service in which patients receive intravenous (IV) or injectable medications, fluids, or nutritional therapies at home instead of in a hospital or clinic. It involves the administration of treatments such as antibiotics, chemotherapy, pain management drugs, parenteral nutrition, hydration therapy and immune therapies using specialized infusion equipment and professional clinical supervision. The primary purpose of home infusion therapy is to provide convenient, cost-effective and patient-centered medical care while reducing the need for prolonged hospital stays or frequent clinic visits. The home infusion therapy market consists of revenues generated by entities (organizations, sole traders and partnerships) by providing infusion devices, intravenous administration sets, vascular access products and related support services for the delivery of medications and nutritional products in home care settings. The market includes infusion pumps, intravenous sets, IV cannulas and needleless connectors used for the administration of therapies such as total parenteral nutrition, anti-infective therapy, hydration therapy, chemotherapy and specialty pharmaceutical infusions. These products and services are used by patients receiving care outside hospitals, including in private homes, long-term care facilities and outpatient settings.

Home Infusion Therapy Market Segmentation

The home infusion therapy market is segmented by product, by administration, by application and by end user.

By Product –
The home infusion therapy market is segmented by product into:

• a) Infusion Pumps
• b) Intravenous Sets
• c) Iv Cannulas
• d) Needleless Connectors

The infusion pumps market was the largest segment of the home infusion therapy market segmented by product, accounting for 49.5% or $17,643.3 million of the total in 2025. Going forward, the needleless connectors segment is expected to be the fastest-growing segment in the home infusion therapy market segmented by product, at a CAGR of 10.0% during 2025-2030.

By Administration –
The home infusion therapy market is segmented by administration into:

1. a) Intravenous
2. b) Subcutaneous
3. c) Epidural
4. d) Intramuscular

The intravenous market was the largest segment of the home infusion therapy market segmented by administration, accounting for 70.1% or $24,964.2 million of the total in 2025. Going forward, the subcutaneous segment is expected to be the fastest-growing segment in the home infusion therapy market segmented by administration, at a CAGR of 10.0% during 2025-2030.

By Application –
The home infusion therapy market is segmented by application into:

• a) Total Parenteral Nutrition
• b) Anti-Infective Therapy
• c) Hydration Therapy
• d) Chemotherapy
• e) Ivig Or Specialty Pharmaceuticals
• f) Other Applications

The anti-infective therapy market was the largest segment of the home infusion therapy market segmented by application, accounting for 28.0% or $9,973.3 million of the total in 2025. Going forward, the IVIg or specialty pharmaceuticals segment is expected to be the fastest-growing segment in the home infusion therapy market segmented by application, at a CAGR of 11.4% during 2025-2030.

By End User –
The home infusion therapy market is segmented by end user into:

• a) Patients
• b) Nurse
• c) Other End Users

The patients market was the largest segment of the home infusion therapy market segmented by end user, accounting for 56.8% or $20,241.3 million of the total in 2025. Going forward, the patients segment is expected to be the fastest-growing segment in the home infusion therapy market segmented by end user, at a CAGR of 9.5% during 2025-2030.

By Geography - The home infusion therapy market is segmented by geography into:

o Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
o South East Asia
• Indonesia
o North America
• USA
• Canada
o South America
• Brazil
o Western Europe
• France
• Germany
• UK
• Italy
• Spain
o Eastern Europe
• Russia
o Middle East
o Africa

North America was the largest region in the home infusion therapy market, accounting for 38.5% or $13,695.3 million of the total in 2025. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the home infusion therapy market will be Asia Pacific and North America where growth will be at CAGRs of 10.3% and 8.8% respectively. These will be followed by Eastern Europe and Middle East where the markets are expected to grow at CAGRs of 8.5% and 8.0% respectively.

Home Infusion Therapy Market Drivers

The key drivers of the home infusion therapy market include: Growing Aging Population During the forecast period, the growing aging population is projected to significantly drive the growth of the home infusion therapy market. The expanding elderly population is increasing the need for ongoing medical support, chronic disease management and intravenous therapies that can be delivered safely at home. Older adults often require long-term medication administration, nutritional support, hydration therapy and post-hospital recovery care over extended periods. Home-based treatment reduces the physical strain associated with frequent hospital visits and improves comfort for aging patients with mobility limitations. It also helps lower the risk of complications linked to prolonged hospitalization and supports more personalized care in familiar surroundings. Healthcare providers are increasingly adopting home-focused care models to meet the complex needs of elderly patients. Growing life expectancy and higher rates of age-related illnesses are further strengthening demand for long-term in-home clinical support. The availability of trained caregivers and remote patient monitoring technologies is also improving the feasibility of managing elderly patients outside traditional healthcare settings. The growing aging population growth contribution during the forecast period in 2026 is 1.3%.

Home Infusion Therapy Market Restraints

The key restraints on the home infusion therapy market include: Shortage Of Skilled Healthcare Professionals During the forecast period, shortage of skilled healthcare professionals are expected to pose challenges to the growth of the home infusion therapy market. The limited availability of trained nurses, infusion specialists and home healthcare professionals is restricting the ability to deliver complex therapies safely outside hospital settings. Many treatments require careful drug preparation, catheter management, patient monitoring and emergency response capabilities that depend on experienced staff. Workforce shortages can lead to scheduling delays, reduced service coverage and increased pressure on existing healthcare teams. Rural and underserved areas are especially affected due to limited access to qualified professionals. This challenge reduces the ability of providers to expand home-based clinical services efficiently. Growth affected by the shortage of skilled healthcare professionals during the forecast period in 2026 is -2.0%.

Chromatography Resins Market Competitive Landscape

Major Competitors are:

The Boeing Company

Lockheed Martin Corporation

Mitsubishi Heavy Industries

Calspan Corporation

Siemens AG

Other Competitors Include:

Airbus SE

Omega Engineering, Inc.

Taikisha Ltd.

Aiolos Engineering Corporation

Mahle

Baxter International

Medtronic plc

Terumo Corporation

Mindray Bio-Medical Electronics Co., Ltd.

Nipro Corporation

B. Braun

Moog Medical

BD (Becton Dickinson)

ICU Medical Inc.

Lepu Medical Technology (Beijing) Co., Ltd.

Contec Medical Systems

JMS Co., Ltd.

Koru Medical Systems

Wooyoung Medical

Fresenius Kabi Ltd.

PromptCare

Option Care Health Inc.

KabaFusion Holdings LLC

CSI Pharmacy LLC

Healix Infusion Therapy Inc.

InfuCare Rx Inc.

Integrated Home Care Services Inc.

IVX Health Inc.

IV Solutions Group, LLC

Oso Home Care, Inc.

Palmetto Infusion Services

Premier Infusion Care

Basic Home Infusion

Beacon Infusion Healthcare Services LLC

CarepathRx, LLC

BioPlus Specialty Infusion

Metro Infusion Center

Cencora (AmerisourceBergen)

Eitan Medical Ltd.

CSL Behring

Kroger Specialty Infusion

Home Infusion Therapy Market Trends

Major trends shaping the home infusion therapy market include: Innovative At-Home Cancer Therapy Delivery Solutions For Personalized Treatment Support Key players operating in the home infusion therapy market are focusing on expanding in-home infusion care services to improve treatment accessibility and patient convenience for individuals requiring complex therapies. Companies are increasingly investing in home-based oncology care models and infusion delivery solutions to reduce hospital dependency and improve patient-centered healthcare services. For instance, in January 2026, Luminate Medical, an Ireland-based medical technology company, raised $21 million to expand in-home delivery of drug infusion therapies for cancer patients. The company focused on developing home-based oncology infusion services alongside medical devices designed to reduce chemotherapy side effects and improve patient treatment experiences. The funding supported the expansion of at-home cancer care capabilities and strengthened the company’s efforts to improve accessibility and convenience in infusion-based oncology treatment. Expansion Of Personalized Home Infusion Therapy Services For Improved Treatment Accessibility Major companies operating in the home infusion therapy market are expanding home infusion nursing services to improve patient access to specialized treatment and strengthen home-based healthcare delivery. Companies are increasing investments in infusion nursing capabilities and chronic disease management services to support the rising demand for at-home infusion therapies. They are also emphasizing integrated care models to improve treatment convenience, patient monitoring and long-term therapy management across home healthcare settings. For instance, in February 2024, Dynamic Access, LLC, a US-based vascular access solutions provider, launched its new affiliate brand, Dynamic Infusion, to provide home infusion nursing services for patients with chronic conditions. The services were designed to support patients suffering from autoimmune disorders, hemophilia, Crohn’s disease, rheumatoid arthritis, multiple sclerosis and other chronic illnesses through specialized home-based infusion care and nursing support.

Opportunities And Recommendations In The Home Infusion Therapy Market

Opportunities – The top opportunities in the home infusion therapy market segmented by product will arise in the infusion pumps segment, which will gain $9,988.2 million of global annual sales by 2030. The top opportunities in the home infusion therapy market segmented by administration will arise in the intravenous segment, which will gain $13,078.5 million of global annual sales by 2030. The top opportunities in the home infusion therapy market segmented by application will arise in the anti-infective therapy segment, which will gain $6,061.6 million of global annual sales by 2030. The top opportunities in the home infusion therapy market segmented by end user will arise in the patients segment, which will gain $11,593.5 million of global annual sales by 2030. The home infusion therapy market size will gain the most in the USA at $6,308.7 million. Recommendations- To take advantage of the opportunities, The Business Research Company recommends the home infusion therapy companies to focus on expanding home-based oncology infusion services, focus on integrated home infusion care and chronic disease management, focus on connected remote monitoring and digital infusion platforms, focus on expanding needleless connector solutions for home infusion care, focus on expanding subcutaneous home infusion therapies, expand in emerging markets, continue to focus on developed markets, focus on value-based and reimbursement-aligned pricing strategies, focus on clinical education and outcome-based awareness programs, focus on expanding ivig and specialty pharmaceutical home infusion services, focus on strengthening patient-centered home infusion care models.